Anixa Biosciences (ANIX) Institutional Ownership → The Crypto 9-5 Escape Plan (From Crypto 101 Media) (Ad) Free ANIX Stock Alerts $3.00 +0.13 (+4.53%) (As of 05/10/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Anixa Biosciences (NASDAQ:ANIX)CurrentInstitutional OwnershipPercentage29.13%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$2.01MNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$97.58K Get ANIX Insider Trade Alerts Want to know when executives and insiders are buying or selling Anixa Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ANIX Institutional Buying and Selling by Quarter Ad Crypto 101 MediaThe Crypto 9-5 Escape PlanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Anixa Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/6/2024 Staley Capital Advisers Inc.10,000$31K0.0%N/A0.031% 4/24/2024 Simplicity Wealth LLC13,969$44K0.0%N/A0.044% 1/24/2024 International Assets Investment Management LLC54,320$2.11M0.0%+274.6%0.171% 11/9/2023UBS Group AG604,439$1.98M0.0%-4.7%1.945% 10/24/2023 Dakota Wealth Management15,000$49K0.0%N/A0.048% 10/24/2023 Mission Wealth Management LP501,168$1.64M0.1%N/A1.613% Get the Latest News and Ratings for ANIX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Anixa Biosciences and its competitors with MarketBeat's FREE daily newsletter. 7/25/2023Concorde Asset Management LLC15,481$50K0.0%N/A0.050% 7/14/2023 Westside Investment Management Inc.13,800$44K0.0%N/A0.045% 5/1/2023Virtu Financial LLC18,409$79K0.0%N/A0.060% 4/27/2023Simplicity Solutions LLC15,481$67K0.0%N/A0.050% 4/19/2023 International Assets Investment Management LLC14,500$62K0.0%+31.8%0.047% 2/8/2023 Cambridge Investment Research Advisors Inc.40,100$170K0.0%+167.3%0.130% 2/7/2023 Nations Financial Group Inc. IA ADV13,000$55K0.0%N/A0.042% 1/30/2023 International Assets Investment Management LLC11,000$47K0.0%N/A0.036% 11/10/2022UBS Group AG621,691$3.06M0.0%+2.7%2.028% 10/25/2022 Raymond James & Associates60,846$299K0.0%-7.1%0.198% 10/17/2022 Cambridge Investment Research Advisors Inc.15,000$74K0.0%N/A0.049% 7/22/2022 Gemmer Asset Management LLC35,000$107K0.0%N/A0.115% 4/28/2022Keybank National Association OH15,510$42K0.0%N/A0.051% 2/22/2022Tyler Stone Wealth Management21,008$62K0.0%N/A0.070% 2/14/2022Long Focus Capital Management LLC21,297$63K0.0%N/A0.071% 2/10/2022B. Riley Wealth Management Inc.17,000$50K0.0%+41.7%0.056% 2/8/2022 Raymond James & Associates56,902$169K0.0%+10.4%0.189% 11/16/2021 Adirondack Trust Co.7,000$33K0.0%N/A0.023% 11/15/2021Marshall Wace LLP41,973$200K0.0%N/A0.140% 11/12/2021Renaissance Technologies LLC212,200$1.01M0.0%+70.4%0.709% 11/12/2021Geode Capital Management LLC263,951$1.26M0.0%+23.5%0.881% 11/9/2021BlackRock Inc.110,292$525K0.0%-6.6%0.368% 11/2/2021 Raymond James & Associates51,550$246K0.0%-4.6%0.172% 11/1/2021 Cedar Brook Financial Partners LLC10,000$48K0.0%N/A0.033% 10/22/2021 Spire Wealth Management14,500$69K0.0%-17.1%0.048% 10/8/2021 Wealth Alliance Advisory Group LLC16,413$78K0.0%N/A0.055% 8/16/2021State Street Corp23,287$90K0.0%N/A0.078% 8/13/2021Renaissance Technologies LLC124,499$483K0.0%N/A0.416% 8/13/2021Northern Trust Corp61,282$238K0.0%+24.8%0.205% 8/13/2021Geode Capital Management LLC213,804$829K0.0%+26.5%0.714% 8/13/2021Vanguard Group Inc.1,302,231$5.05M0.0%+1.7%4.348% 8/11/2021 Bank of New York Mellon Corp43,302$168K0.0%-15.0%0.145% 5/21/2021Citadel Advisors LLC19,682$92K0.0%+35.8%0.063% 5/18/2021Citadel Advisors LLC19,682$92K0.0%+35.8%0.063% [URGENT] DO NOT Touch These AI Stocks! (Ad)Artificial intelligence stocks are carrying the market. One of them, Nvidia, recently became the seventh company ever to hit a $1 trillion market cap. But is this AI rally over?Click here for our #1 AI Stock for 2024 and Beyond5/18/2021Jane Street Group LLC26,093$122K0.0%N/A0.083% 5/14/2021First Manhattan Co.6,500$30K0.0%N/A0.021% 5/14/2021Stifel Financial Corp20,000$94K0.0%N/A0.064% 5/13/2021Barclays PLC9,998$47K0.0%N/A0.032% 5/12/2021Geode Capital Management LLC168,958$790K0.0%+51.1%0.538% 5/12/2021UBS Group AG587,481$2.75M0.0%-5.0%1.869% 5/7/2021BlackRock Inc.102,220$478K0.0%+8.8%0.325% 4/28/2021 Wealth Alliance Advisory Group LLC20,100$94K0.0%N/A0.064% 4/27/2021 Dorsey Wright & Associates8,093$38K0.4%N/A0.026% 4/27/2021Concorde Asset Management LLC13,000$61K0.0%N/A0.041% 2/11/2021B. Riley Wealth Management Inc.12,000$37K0.0%N/A0.046% 2/11/2021Northern Trust Corp49,291$151K0.0%-5.2%0.189% 2/9/2021 Bank of New York Mellon Corp51,969$160K0.0%+32.0%0.199% 2/5/2021BlackRock Inc.93,942$289K0.0%+8.0%0.360% 11/17/2020Jane Street Group LLC18,495$45K0.0%N/A0.078% 11/13/2020Morgan Stanley14,484$35K0.0%-43.1%0.061% (Data available from 1/1/2016 forward) ANIX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ANIX shares? During the previous two years, 14 institutional investors and hedge funds held shares of Anixa Biosciences. The most heavily invested institutionals were International Assets Investment Management LLC ($2.11M), UBS Group AG ($1.98M), Mission Wealth Management LP ($1.64M), Raymond James & Associates ($299K), Cambridge Investment Research Advisors Inc. ($170K), Gemmer Asset Management LLC ($107K), and Virtu Financial LLC ($79K).Learn more on ANIX's institutional investors. What percentage of Anixa Biosciences stock is owned by institutional investors? 29.13% of Anixa Biosciences stock is owned by institutional investors. Learn more on ANIX's institutional investor holdings. Which institutional investors have been buying Anixa Biosciences stock? Of the 13 institutional investors that purchased Anixa Biosciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Mission Wealth Management LP ($501.17K), International Assets Investment Management LLC ($54.32K), Cambridge Investment Research Advisors Inc. ($40.10K), Gemmer Asset Management LLC ($35K), Virtu Financial LLC ($18.41K), UBS Group AG ($16.29K), and Concorde Asset Management LLC ($15.48K). How much institutional buying is happening at Anixa Biosciences? Institutional investors have bought a total of 762,013 shares in the last 24 months. This purchase volume represents approximately $2.64M in transactions. Which Anixa Biosciences major shareholders have been selling company stock? The following institutional investors have sold Anixa Biosciences stock in the last 24 months: UBS Group AG ($29.84K), and Raymond James & Associates ($4.67K). How much institutional selling is happening at Anixa Biosciences? Institutional investors have sold a total of 34,512 shares in the last 24 months. This volume of shares sold represents approximately $120.56K in transactions. Related Companies: Milestone Pharmaceuticals Major Shareholders ProPhase Labs Major Shareholders Aclaris Therapeutics Major Shareholders Eton Pharmaceuticals Major Shareholders Clearside Biomedical Major Shareholders Oncolytics Biotech Major Shareholders Spero Therapeutics Major Shareholders Chimerix Major Shareholders Q32 Bio Major Shareholders Oramed Pharmaceuticals Major Shareholders This page (NASDAQ:ANIX) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersThe Crypto 9-5 Escape PlanCrypto 101 MediaDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHow Biden has already won 2024Porter & CompanyRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchMissed NVDA? Buy this AI stock NOWChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anixa Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.